SKI Market

Indian Indices

Nifty

24,971.90 -140.50
(-0.56%)

Sensex

81,896.79 -511.38
( -0.62%)

Bank Nifty

56,059.35 -193.50
( -0.34%)

Nifty IT

38,414.10 -577.35
( -1.48%)

Global Indices

Nasdaq

42,233.20 40.53
(0.10%)

Dow Jones

5,989.55 -12.32
(-0.21%)

Hang Seng

38,330.35 -72.88
(-0.19%)

Nikkei 225

8,758.04 -16.61
(-0.19%)

Forex

USD-INR

86.67 0.24
(0.27%)

EUR-INR

99.45 0.06
(0.06%)

GBP-INR

116.39 0.20
(0.17%)

JPY-INR

0.60 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Wanbury Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524212

INE107F01022

18.0865417

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WANBURY

29.71

907.42

EPS(TTM)

Face Value()

Div & Yield %

9.32

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	575.65	499.65	511.19	392.52	367.45	391.37
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	575.65	499.65	511.19	392.52	367.45	391.37
Other Income	2.99	0.91	77.88	2.40	83.78	9.33
Stock Adjustments	3.89	-29.13	24.79	7.20	-5.99	5.06
Total Income	582.53	471.43	613.86	402.12	445.24	405.76
EXPENDITURE :
Raw Materials	306.52	274.31	325.07	228.53	169.75	201.26
Power & Fuel Cost	24.58	20.59	18.41	17.13	15.38	14.46
Employee Cost	86.92	81.00	74.81	64.15	67.48	75.89
Other Manufacturing Expenses	13.32	11.43	12.66	9.98	13.77	7.98
Selling & Administrative Expenses	58.51	45.16	55.34	45.49	55.36	63.70
Miscellaneous Expenses	19.69	15.45	14.36	16.42	16.29	17.59
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	509.54	447.94	500.65	381.70	338.02	380.89
Operating Profit	72.99	23.49	113.19	20.42	107.23	24.86
Interest	29.18	21.39	20.61	23.07	32.87	39.88
Gross Profit	43.81	2.10	92.58	-2.65	74.36	-15.02
Depreciation	13.03	12.38	11.45	9.75	9.68	9.97
Profit Before Tax	30.78	-10.28	81.13	-12.40	64.68	-24.99
Tax	0.00	0.00	0.00	2.27	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.38	0.11	-0.35	-2.07	0.21	-0.14
Reported Net Profit	30.40	-10.40	81.47	-12.61	64.46	-24.85
Extraordinary Items	0.49	-0.31	76.06	1.21	82.62	0.12
Adjusted Net Profit	29.91	-10.09	5.41	-13.82	-18.16	-24.97
Adjustment below Net Profit	-0.59	0.26	0.80	-0.44	-0.46	0.31
P & L Balance brought forward	-168.14	-158.01	-240.28	-227.23	-291.23	-266.69
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-138.34	-168.14	-158.01	-240.28	-227.23	-291.23
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	9.28	-3.18	24.94	-5.04	25.79	-10.48
Earnings Per Share(Adj)-Unit Curr	9.28	-3.18	24.94	-5.04	25.79	-10.48
Book Value-Unit Curr	6.70	-2.26	0.57	-52.23	-47.14	-77.40
Book Value(Adj)-Unit Curr	6.70	-2.26	0.57	-52.23	-47.14	-77.40

24,971.90 -140.50 (-0.56%)

81,896.79 -511.38 ( -0.62%)

56,059.35 -193.50 ( -0.34%)

38,414.10 -577.35 ( -1.48%)

42,233.20 40.53 (0.10%)

5,989.55 -12.32 (-0.21%)

38,330.35 -72.88 (-0.19%)

8,758.04 -16.61 (-0.19%)

86.67 0.24 (0.27%)

99.45 0.06 (0.06%)

116.39 0.20 (0.17%)

0.60 0.00 (-0.02%)